Member Info for quercusrobor

lol.....love it...

re..they will retain an interest via their holding in Block - schlum are going to be block energy's largest shareholder

..a refresher for folk recently arrived...
https://www.lse.co.uk/rns/BLOE/major-acqn-of-2-adjacent-blocks-from-schlumberger-a1ubuuzw7d0s5f0.ht

EU recommends use of COVID rapid tests after symptoms emerge

https://www.reuters.com/article/us-health-coronavirus-eu-tests-idUSKBN27Y1N6?taid=5fb54f9684ce3a000150fcbb&utm_campaign=trueAnthem:+Trending+Content&utm_medium=trueAnthem&utm_source=twitter

BRUSSELS (Reuters) - The European Commission recommended on Wednesday the use of rapid COVID-19 antigen tests mostly on people already showing symptoms because it said the kits were deemed less accurate in detecting the virus in asymptomatic cases.

fieldhouse
15 Nov '20 - 11:45 - 16842 of 16843
0 3 1
There is a bizarre aspect to the Pfizer and other potential vaccines.A compete turnaround in political and environmental attitudes that has not been clearly stated.!!!
That is that the new vaccine is GENETICALLY MODIFIED " G M " Dreaded by every European
politician.!!
Are we on the cusp of accepting GM ??
I hope so because the GM lobby have for so long denied the scientific breakthrough that GM can enhance humanity.
My only reserve is that the new vaccine is put through the normal stringent safeguards with no short cuts .
Monsanto made short cuts with GM Soya and Maize. Became known for producing "Frankenstein" food. (They marketed a year to soon and left live ampicillin in the commercial product ! they were in a race with Novartis)
GM would give mankind a huge scientific boost imho

re....This sort of play, sooner rather than later, will backfire big time.
indeed....https://www.ft.com/content/87725d8e-870b-42a4-8f1b-e07ab58c354b

AI hedge fund Voleon suffers in choppy markets
High-performing quant funds lose lustre in turbulent year

this is a computer driven quant fund..............nothing personal..)

re..Conclusion... don’t trust John Bell!
What a dreadful intemperate schoolgirl performance yesterday........WHO are these people?

https://www.bbc.co.uk/news/world-asia-china-54883383

BBC News (https://www.bbc.co.uk/news/world-asia-china-54883383)
Covid: China Sinovac vaccine trial halted in Brazil
The Sinovac clinical trial has been suspended after a "severe adverse" incident, say authorities.

https://twitter.com/MylesMcNulty/status/1325921677641969669

most PI's stiffed on the unrealistic expectations of a few.

Myles McNulty
@MylesMcNulty
·
28 Oct
Glad I’m on holiday this week.
...try harder....why dont you...

re...still doesn't make any sense though
if you go to the sona website +watch the video dem. of how this test works etc.....you will see clearly why this is a complete non-starter....

presumably you would'nt be posting this, in this place without a sound reason.....or am I being fanciful?

do you have a link by a chance..ty

David Norwood still reducing?

more pls...

https://www.dailymail.co.uk/news/article-8884031/Dr-Fauci-warns-early-COVID-19-vaccines-prevent-symptoms-not-block-infect

Dr Fauci warns that early COVID-19 vaccines will only prevent symptoms from arising - not block infection

Dr Anthony Fauci cautioned that early COVID-19 vaccines are aimed at preventing symptoms during Yahoo Finance's All Markets Summit on Monday
'If the vaccine allows you to prevent initial infection, that would be great,' he said. '[But] the primary endpoint [is] to prevent clinically recognizable disease'
At least four vaccine candidates are currently in late-stage clinical trials
Fauci has said he is cautiously optimistic that a vaccine will arrive by year end
But he warned that early vaccines may only be 50 to 60 percent effective

https://www.sharebuyers.co.uk/shares/avacta-shares-going-for-growth-world-moving-rapidly-again/

Going for growth: Avacta primed to rapidly get the world moving once again
October 27, 2020

As part of the ShareBuyers’ going for growth series, we take a look into the growth prospects of Avacta (LON: AVCT), a specialist developer of innovative cancer therapies and diagnostics tools that has been among the best performers across the London markets this year with a gain of over 800% since the start the year.

With its diagnostics division preparing to launch a game-changing saliva-based COVID-19 rapid antigen test that can easily be used at home and read by eye – its surging share price comes as little surprise due to the immense potential to easily support frequent mass testing with the minimal of fuss and unlock the wider economy.

In the UK alone, the demand for antigen testing in the community could be as high as 100 million tests per month in the medium-term. Through our partnerships, we are looking to supply beyond just the UK market.
Alastair Smith, CEO of Avacta

ok tx

re...
I notice as off Friday Spreadex not taking any more trades
where do you see this?....what do you deduce from this? tx

Oct 23 2020, 17:07 32.90 261,800 0.00 0.00 ? £86,132.2 O
Oct 23 2020, 16:35 32.90 5,500 31.00 31.50 Buy £1,809.5 UT
Oct 23 2020, 16:30 31.0001 69,200 31.00 31.50 Sell £21,452.0692 O
Oct 23 2020, 16:29 31.0001 50,000 31.00 31.50 Sell £15,500.05 O
Oct 23 2020, 16:29 31.0001 52,675 31.00 31.50 Sell £16,329.302675 O